Simplifying Global Compliance
Electronic Document Management Systems for Drugmakers
| Quantity Discounts | 1 - 2 $287.00 | 3 - 4 $258.00 | 5 - 6 $244.00 | 7 - 9 $230.00 | 10 - 9999 $215.00 |
 |
|||||
Converting a paper-based documentation system into an electronic document management system (eDMS) is a win-win for drug manufacturers, the FDA and the EU.
But difficulties lie in the complexity of converting from paper to electronic: the selection, design, implementation and validation of your plan. Electronic Document Management Systems for Drugmakers, a new management report from FDAnews, tackles all those difficulties — the key concepts, various issues and tricky interrelationships with other systems — that you must deal with during a conversion to a validated eDMS. With the help of expert author Markus Roemer, you'll dig into how to begin making changes to your company's documentation management — including both knowledge and information management — as well as to documents and records relating to SOP management, training management, changes, deviations, production and warehouse records , records from the laboratory sector, and more. And, you'll begin to see how a paper-to-electronic conversion will completely change — and simplify — your existing procedures, processes and how you handle all your information and data. Specifically, you will learn:
Completing a paper-to-electronic conversion is a complex undertaking. Let an acknowledged expert give you assistance, right from the beginning. Order your copy of Electronic Document Management Systems for Drugmakers today. Meet the Author Markus Roemer is an independent consultant and auditor with Comes Compliance Services in Germany. He has worked as a quality project manager for GMP projects, electronic batch recording systems, quality release management and application development, and auditing for Propack Data GmbH – Rockwell Automation. He has also served as director of compliance management at Systec & Services and senior validation consultant for Invensys Validation Technologies. He is a founder and member of IT Pharma Validation Europe and ambassador for Germany, Austria and Switzerland at the International Society of Pharmaceutical Engineering (ISPE). Order Your Copy Today!
|
Available Format
Table of Contents
Who Will Benefit
Multi-user AccessSave money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library – a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information. Our GuaranteeNot satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price. | ||||
